Literature DB >> 12851880

Colonic epithelial functional phenotype varies with type and phase of experimental colitis.

Emiko Mizoguchi1, Ramnik J Xavier, Hans-Christian Reinecker, Hirofumi Uchino, Atul K Bhan, Daniel K Podolsky, Atsushi Mizoguchi.   

Abstract

BACKGROUND & AIMS: Colonic crypt elongation occurs during both chronic colitis and in the recovery phase of acute colitis. The impact of these alterations on epithelial cell functions is not fully defined.
METHODS: DNA microarray analysis of freshly isolated colonic epithelial cells (CECs) from acute and chronic colitis was performed, and the results were confirmed by reverse transcription polymerase chain reaction. Localization of the selected molecules was examined by immunohistochemistry using newly generated antibodies. The function of selected molecules detected in this study was examined by administering the specific inhibitors in dextran sodium sulfate (DSS) colitis.
RESULTS: Several detoxification-associated molecules, which contribute to prevent inflammation by regulating physiological balance under normal conditions, were markedly down-regulated, and anti-inflammatory molecules, which are not normally expressed, were up-regulated in the CEC under the chronic colitis. Among the detoxification-associated molecules, carbonic anhydrase IV was specifically down-regulated in CEC of Th2- but not Th1-mediated colitis. Functionally, inhibition of carbonic anhydrase activity led to the enhancement of recovery from DSS-induced acute colitis by directly stimulating CEC proliferation. Increased expression of regeneration-associated molecules such as regenerating gene-III gamma was detectable in the CEC of acute and chronic colitis but not in the recovery phase of colitis. The expression of this molecule was restricted in surface epithelium and upper crypts but not lower crypts.
CONCLUSIONS: These studies suggest that functional alterations, which result in either the exacerbation or the suppression of colitis, coexist in the CEC during chronic colitis. CEC functions are likely to be differentially regulated in the context of the stage and mechanism of colitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851880     DOI: 10.1016/s0016-5085(03)00665-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  39 in total

1.  Role of the xenobiotic receptor in inflammatory bowel disease.

Authors:  Razvan Arsenescu; Violeta Arsenescu; Jian Zhong; Munira Nasser; Razvan Melinte; R W Cameron Dingle; Hollie Swanson; Willem J de Villiers
Journal:  Inflamm Bowel Dis       Date:  2010-09-27       Impact factor: 5.325

Review 2.  Inflammatory bowel disease, past, present and future: lessons from animal models.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

Review 3.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

4.  Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation.

Authors:  Colin Reardon; Matthias Lechmann; Anne Brüstle; Mélanie G Gareau; Naomi Shuman; Dana Philpott; Steven F Ziegler; Tak W Mak
Journal:  Immunity       Date:  2011-08-04       Impact factor: 31.745

5.  Angiotensin II inhibits P-glycoprotein in intestinal epithelial cells.

Authors:  Anoop Kumar; Shubha Priyamvada; Vikas Soni; Arivarasu N Anbazhagan; Tarunmeet Gujral; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja; Seema Saksena
Journal:  Acta Physiol (Oxf)       Date:  2019-07-01       Impact factor: 6.311

6.  Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.

Authors:  Andrew J McDermott; Charles R Frank; Nicole R Falkowski; Roderick A McDonald; Vincent B Young; Gary B Huffnagle
Journal:  Gut Microbes       Date:  2014-07-21

7.  Citrobacter rodentium Infection Inhibits Colonic P-glycoprotein Expression.

Authors:  Mitul Patel; Anoop Kumar; Dulari Jayawardena; Shubha Priyamvada; Arivarasu N Anbazhagan; Waddah A Alrefai; Ravinder K Gill; Pradeep K Dudeja; Seema Saksena
Journal:  Gene Rep       Date:  2019-10-31

8.  Expression profiling reveals novel innate and inflammatory responses in the jejunal epithelial compartment during infection with Trichinella spiralis.

Authors:  Pamela A Knight; Alan D Pemberton; Kevin A Robertson; Douglas J Roy; Steven H Wright; Hugh R P Miller
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 9.  Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease.

Authors:  In-Ah Lee; Alan Kamba; Daren Low; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 10.  Is the sugar always sweet in intestinal inflammation?

Authors:  Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.